Heart failure is a complex clinical syndrome and represents the final path of numerous heart
diseases. Coronary artery disease is recognized as the primary risk factor for heart failure …

There has been a significant increase in the use of short-term percutaneous ventricular
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …

Since the publication of the 2015 EAPCI consensus on rotational atherectomy, the number
of percutaneous coronary interventions (PCI) performed in patients with severely calcified …

Objectives The authors used the BCIS (British Cardiovascular Intervention Society)
database to define the factors associated with percutaneous coronary intervention (PCI) …

Aims: The aim of this study was to investigate nationwide trends and clinical outcomes of the
Impella device for cardiogenic shock (CS) and high-risk percutaneous coronary intervention …

Current guidelines, rarely if at all, address decision-making for revascularization when
bypass surgery is not a possibility for high-risk cases. Patients who are surgically turned …

Aims To report the incidence, the predictors and clinical impact of device-related
complications (DRCs) in the IMP-IT (IMPella Mechanical Circulatory Support Device in Italy) …

Background: Patients and mechanical circulatory support assortment, as well as
periprocedural and post-procedural clinical outcomes in complex high-risk percutaneous …

Objective To assess sex‐based differences in clinical outcomes following complex and high‐
risk but indicated percutaneous coronary intervention (CHiP). Background CHiP is …

We aimed to characterize the performance and safety of percutaneous coronary intervention
(PCI) in complex, high-risk indicated procedure (CHIP) and high-bleeding-risk (HBR) …